In conclusion, our results shed light on the efficacy of PHD1 knockout in activating several important molecules, signaling pathways and networks, resulting in cardioprotection against myocardial infarction, suggesting the need to examine PHD1 for its therapeutic potential further. The gene discussed is EGLN2; the disease is myocardial infarction.